1 / 4

Supplemental Data

Supplemental Data. Lyndsay Harris corresponding author. Figure X Associations of IGF-IR signatures in combination with IGF1 mRNA and outcome.

yardley
Download Presentation

Supplemental Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supplemental Data Lyndsay Harris corresponding author

  2. Figure X Associations of IGF-IR signatures in combination with IGF1 mRNA and outcome 1. HR: hazard ratio; 2. 95% CI: 95% confidential intervals; 3. IGF activation score: -1=no activation, 0= intermediate; 1=activation, which was derived from the Pearson correlation between the IGF gene signature pattern created by Creighton et al. and the gene expression value of the tumor generated by illumina microarray assays in Italy study. 4. Adjustment for disease stage, tumor grade, lymph node involvement status and estrogen receptor status. 5. IGF1 mRNA was a binary variable (high= greater or equal to the median of IGF 1 mRNA, low=less than the median of the expression) generated by using quantitative RT-PCR in tumors from Italy study. The Univariate and multivariate Cox proportional hazard regression models evaluated the association of the IGF-1R signature and patient survival.

  3. 1.00 0.75 0.50 Survival Distribution Function 0.25 0.00 0 20 40 60 80 100 120 Time (month) Supplemental Figure 1: Kaplan-Meier disease free survival curves in Turin cohort stratified by molecular subtypes LumA (n=49) Normal (n=40) Her2 (n=33) Basal (n=30) LumB (n=52) P=0.0039

  4. 1.00 0.75 0.50 Survival Distribution Function 0.25 0.00 0 20 40 60 80 100 120 Time (month) Supplemental Figure 2: Kaplan-Meier overall survival curves in the Turiin cohort stratified by molecular subtypes LumA (n=49) Normal (n=40) Her2 (n=33) LumB (n=52) Basal (n=30) P=0.0019

More Related